Nagarjuna Drugs Ltd. - Research Center
530064 NAGDRUG Group (XD) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 00 | |
|---|---|
| Sales | 0.66 |
| Operating profit | -0.11 |
| Interest | 0.18 |
| Gross profit | -0.29 |
| EPS (Rs) | -0.74 |
Half yearly
results in details
| Sep ' 00 | |
|---|---|
| Other income | - |
| Stock adjustment | - |
| Raw material | - |
| Power and fuel | - |
| Employee expenses | - |
| Excise | - |
| Admin and selling expenses | - |
| Research and development expenses | - |
| Expenses capitalised | - |
| Other expenses | 0.77 |
| Provisions made | - |
| Depreciation | 0.10 |
| Taxation | - |
| Net profit / loss | -0.39 |
| Extra ordinary item | - |
| Prior year adjustments | - |
| Equity capital | 5.24 |
| Equity dividend rate | - |
| Agg.of non-prom. shares (Lacs) | - |
| Agg.of non promotoholding (%) | - |
| OPM (%) | -16.67 |
| GPM (%) | - |
| NPM (%) | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis